| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, New York 14263 [P. F. C., B. G., E. K., C. W. P.], and Department of Medicinal Chemistry, J. Hillis Miller Health Center, University of Florida, Gainesville, Florida 32610 [R. J. B., N. S.]
Eleven novel spermidine (SPD) derivatives were synthesized as potential anticancer agents and evaluated for their ability to compete with [3H]SPD for cellular uptake, to inhibit cell growth, to affect polyamine biosynthesis, to suppress enzyme activity, and to substitute for SPD in supporting growth of cultured L1210 leukemia cells. The compounds included a series of N4-SPD derivatives (N4-methyl-SPD, N4-ethyl-SPD, N4-acetyl-SPD, N4-hexyl-SPD, N4-hexanoyl-SPD, N4-benzyl-SPD, and N4-benzoyl-SPD) and a series of N1,N8-SPD derivatives [N1,N8-bis(ethyl)-SPD, N1,N8-bis(acetyl)-SPD, N1,N8-bis(propyl)-SPD, and N1,N8-bis(propionyl)-SPD]. Uptake studies revealed N4-alkyl derivatives to be the most effective competitive inhibitors of [3H]SPD uptake (Ki, 26 to 43 µM) followed by N1,N8-alkyl derivatives (Ki, 71 to 115 µM), then N4-acyl derivatives (Ki, 115 to >500 µM), and N1,N8-acyl derivatives (Ki, >500 µM). The data indicate the relative importance of the terminal amines and of charge as determinants of cellular uptake. Of the 11 derivatives, only N4-hexyl-SPD, N1,N8-bis(ethyl)-SPD, and N1,N8-bis(propyl)-SPD demonstrated antiproliferative activity at 0.1 mM with 50%-inhibitory concentration values at 48 h of 30, 40, and 50 µM, respectively. In the case of the N1,N8-SPD derivatives, recovery from growth inhibition was enhanced considerably by exogenous SPD, suggesting involvement of polyamine depletion. At 10 to 30 µM, both N1,N8-bis(ethyl)-SPD and N1,N8-bis(propyl)-SPD (but not N4-hexyl-SPD) inhibited polyamine biosynthesis as indicated by significant reductions in polyamine pools and in biosynthetic enzyme activities. The more effective of the two, N1,N8-bis(ethyl)-SPD, depleted intracellular putrescine and SPD and reduced spermine by
50% at 96 h and decreased ornithine and S-adenosylmethionine decarboxylase activities by 98 and 62%, respectively. Since neither derivative (at 5 mM) directly inhibited these enzymes from untreated cell extracts by significantly more than SPD itself, it is suspected that they act by regulating enzyme levels. As a measure of regulatory potential of the derivatives, ornithine decarboxylase was assayed in cells treated for 24 h and compared to the effects of 10 µM SPD which reduced the enzyme activity by 80%. None of the N4-SPD derivatives affected ornithine decarboxylase activity, while N1,N8-bis(ethyl)- and (propyl)-SPD were nearly as effective as SPD. Apparently, the central amine of the molecule is critical for regulatory function. Neither of the N1,N8-SPD derivatives was capable of functionally substituting for the depleted SPD pools as determined by their inability to prevent
-difluoromethylornithine-mediated cytostasis. By contrast, several of the N4-SPD derivatives were effective in this activity, suggesting that the N1,N8-terminal amines are critical for SPD function. It is concluded that inhibition of cell growth via polyamine depletion occurs with those SPD derivatives [i.e., N1,N8-bis(ethyl)- or (propyl)-SPD] which regulate biosynthetic enzyme activities in a manner similar to polyamines but which, unlike the natural polyamines, are incapable of performing in functions essential for cell growth.
1 This investigation was supported in part by Grants CA-33321, CA-22153, and CA-24538 from the National Cancer Institute, Department of Health, Education, and Welfare.
2 To whom requests for reprints should be addressed.
3 Recipient of American Cancer Society Postdoctoral Fellowship Grant PF-2425.
Received 10/11/83. Revised 12/27/84. Accepted 1/30/85.
This article has been cited by other articles:
![]() |
D. L. Kramer, P. Diegelman, J. Jell, S. Vujcic, S. Merali, and C. W. Porter Polyamine Acetylation Modulates Polyamine Metabolic Flux, a Prelude to Broader Metabolic Consequences J. Biol. Chem., February 15, 2008; 283(7): 4241 - 4251. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Petros, G. F. Graminski, S. Robinson, M. R. Burns, N. Kisiel, R. F. Gesteland, J. F. Atkins, D. L. Kramer, M. T. Howard, and R. S. Weeks Polyamine Analogs with Xylene Rings Induce Antizyme Frameshifting, Reduce ODC Activity, and Deplete Cellular Polyamines J. Biochem., November 1, 2006; 140(5): 657 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jarvinen, T. A. Keinanen, N. A. Grigorenko, A. R. Khomutov, A. Uimari, J. Vepsalainen, A. Narvanen, L. Alhonen, and J. Janne Guide Molecule-driven Stereospecific Degradation of {alpha}-Methylpolyamines by Polyamine Oxidase J. Biol. Chem., February 24, 2006; 281(8): 4589 - 4595. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kee, S. Vujcic, S. Merali, P. Diegelman, N. Kisiel, C. T. Powell, D. L. Kramer, and C. W. Porter Metabolic and Antiproliferative Consequences of Activated Polyamine Catabolism in LNCaP Prostate Carcinoma Cells J. Biol. Chem., June 25, 2004; 279(26): 27050 - 27058. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Wallace, J. Duthie, D. M. Evans, S. Lamond, K. M. Nicoll, and S. D. Heys Alterations in Polyamine Catabolic Enzymes in Human Breast Cancer Tissue Clin. Cancer Res., September 1, 2000; 6(9): 3657 - 3661. [Abstract] [Full Text] |
||||
![]() |
R. J. Bergeron, R. L. Merriman, S. G. Olson, J. Wiegand, J. Bender, R. R. Streiff, and W. R. Weimar Metabolism and Pharmacokinetics of N ,N11-Diethylnorspermine in a Cebus apella Primate Model Cancer Res., August 1, 2000; 60(16): 4433 - 4439. [Abstract] [Full Text] |
||||
![]() |
F. A. L. M. Eskens, G. A. Greim, C. van Zuylen, I. Wolff, L. J. Denis, A. S. Th. Planting, F. A. Muskiet, J. Wanders, N. C. Barbet, L. Choi, et al. Phase I and Pharmacological Study of Weekly Administration of the Polyamine Synthesis Inhibitor SAM 486A (CGP 48 664) in Patients with Solid Tumors Clin. Cancer Res., May 1, 2000; 6(5): 1736 - 1743. [Abstract] [Full Text] |
||||
![]() |
S. Singh, S. K. Puri, S. K. Singh, R. Srivastava, R. C. Gupta, and V. C. Pandey Characterization of Simian Malarial Parasite (Plasmodium knowlesi)-induced Putrescine Transport in Rhesus Monkey Erythrocytes. A NOVEL PUTRESCINE CONJUGATE ARRESTS IN VITRO GROWTH OF SIMIAN MALARIAL PARASITE (PLASMODIUM KNOWLESI) AND CURES MULTIDRUG RESISTANT MURINE MALARIA (PLASMODIUM YOELII) INFECTION IN VIVO J. Biol. Chem., May 23, 1997; 272(21): 13506 - 13511. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kashiwagi, S. Shibuya, H. Tomitori, A. Kuraishi, and K. Igarashi Excretion and Uptake of Putrescine by the PotE Protein in Escherichia coli J. Biol. Chem., March 7, 1997; 272(10): 6318 - 6323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huber, J. G. Pelletier, K. Torossian, P. Dionne, I. Gamache, R. Charest-Gaudreault, M. Audette, and R. Poulin 2,2'-Dithiobis(N-ethyl-spermine-5-carboxamide) Is a High Affinity, Membrane-impermeant Antagonist of the Mammalian Polyamine Transport System J. Biol. Chem., November 1, 1996; 271(44): 27556 - 27563. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Felschow, J. MacDiarmid, T. Bardos, R. Wu, P. M. Woster, and C. W. Porter Photoaffinity Labeling of a Cell Surface Polyamine Binding Protein J. Biol. Chem., December 1, 1995; 270(48): 28705 - 28711. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kramer, H. Mett, A. Evans, U. Regenass, P. Diegelman, and C. W. Porter Stable Amplification of the S-Adenosylmethionine Decarboxylase Gene in Chinese Hamster Ovary Cells J. Biol. Chem., February 3, 1995; 270(5): 2124 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lessard, C. Zhao, S. M. Singh, and R. Poulin Hormonal and Feedback Regulation of Putrescine and Spermidine Transport in Human Breast Cancer Cells J. Biol. Chem., January 27, 1995; 270(4): 1685 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. McCloskey and A. E. Pegg Altered Spermidine/Spermine N1-Acetyltransferase Activity as a Mechanism of Cellular Resistance to Bis(ethyl)polyamine Analogues J. Biol. Chem., September 8, 2000; 275(37): 28708 - 28714. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |